All Publications

Export 174 results:
Author Title Type [ Year(Asc)]
2020
Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV-1 resistance mutation. Stirrup O, Asboe D, Pozniak A, Sabin C, Gilson R, Mackie N, Tostevin A, Hill T, Dunn D and the UK HIV Drug Resistance Database and the UK Collaborative HIV Cohort. HIV Med, (2020)
2019
Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz+tenofovir+emtricitabine for HIV. Stirrup O, Sabin C, Phillips A, Williams I, Churchill D, Tostevin A, Hill T and Dunn D. J Virus Erad, Volume 5, p.204-211, (2019)
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance. Geretti A, White E, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin C and Dunn D. J Antimicrobial Chemother, Volume 74, p.746-53., (2019)
2018
The association between detected drug resistance mutations and CD4+ T-cell decline in HIV-positive individuals maintained on a failing treatment regimen. Schultze A, Paredes R, Sabin C, Phillips A, Pillay D, Mackie N, Castagna A, Chadwick D, Falconer K, Geretti A et al. Antivir Ther, Volume 23, p.105-116, (2018)
Chronic kidney disease in HIV populations of African descent in the UK. Jose S, Hamzah L, Jones R, Williams D, Winston A, Burns F, Sabin C and Post F. Conference on Retroviruses and Opportunistic Infections, Volume Top Antivir Med. 2018; 26(suppl 1):319s, p.CROI Abstract 731, (2018)
Chronic kidney disease risk in African and Caribbean populations with HIV. Jose S, Hamzah L, Jones R, Williams D, Winston A, Burns F, Phillips A, Sabin C and UK CHIC Study. J Inf Dis, Volume 218, p.1767-1772, (2018)
Commonly prescribed antiretroviral therapy regimens and incidence of AIDS-defining neurological conditions. HIV-CAUSAL Collaboration. Caniglia E, Phillips A, Porter K, Sabin C, Winston A, Logan R, Gill J, Vandenhende M, Barger D, Lodi S et al. J Acquir Immune Defic Syndr, Volume 77, p.102-109, (2018)
A continuum of HIV care describing mortality and loss to follow-up; a longitudinal cohort study. Jose S, Delpech V, Howarth A, Burns F, Hill T, Porter K, Sabin C and UK CHIC Study Steering Committee. Lancet HIV, (2018)
Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance. The HIV-CAUSAL Collaboration. Lodi S, Gunthard H, Dunn D, Garcia F, Logan R, Jose S, Bucher H, Scherrer A, Schneider M, Egger M et al. AIDS, Volume 32, p.327-335., (2018)
Estimation of delay to diagnosis and incidence in HIV using indirect evidence of Stirrup O and Dunn D. BMC Med Res Methodol, Volume 18, p.65, (2018)
Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. IeDEA and COHERE Cohort Collaboration. . Clin Infect Dis, Volume 66, Issue 6, p.893-903, (2018)
Liver ultrasound to evaluate patients with HIV and hepatitis B/C co-infection: coverage and findings from the UK CHIC Study. Garvey L, Jose S, Thornton A, Rodger A, Baghani S, Gilson R, Main J, Taylor C, Dunn D, Chadwick D et al. 4th Joint Conference of British HIV Association (BHIVA) with BASHH, Volume HIV Medicine 2018; 19 (Suppl. 2), s21-s152, p.Poster P394, (2018)
Results of HIV-1 drug resistance tests performed in ART-experienced patients in the UK: patterns 2008-2015. Tostevin A, Dunn D, Stirrup O, Mackie N, Asboe D, Posniak A, Churchill D, Leigh-Brown A, Sabin C, Smit E et al. 4th Joint Conference of the British HIV Association (BHIVA) with BASHH, Volume HIV Medicine 2018; 19 (Suppl. 2), s21-s152, p.Poster P363, (2018)
Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data. UK HIV Drug Resistance Database; UK Collaborative HIV Cohort. Stirrup O, Dunn D, Tostevin A, Sabin C, Pozniak A, Asboe D, Cox A, Orkin C, Martin F and Cane P. AIDS Res Ther, Volume 15, p.11, (2018)
The use of funnel plots with regression as a tool to visually compare HIV treatment outcomes between centres adjusting for patient characteristics and size: a UK Collaborative HIV Cohort study. Gompels M, Michael S, Jose S, Hill T, Trevelion R, Sabin C and May M. HIV Medicine, (2018)
2017
Association between engagement in-care and mortality in HIV-positive persons. Sabin C, Howarth A, Jose S, Hill T, Apea V, Morris S and Burns F. AIDS, 2017 Mar 13, Volume 31, Issue 5, p.653-660, (2017)
An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs. Smit E, White E, Clark D, Churchill D, Zhang H, Collins S, Pillay D, Sabin C, Nelson M, Winston A et al. Antimicrob Chemother, Volume 72, p.2075-82., (2017)
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study. Wang Q, De Luca A, Smith C, Zangerle R, Sambatakou H, Bonnet F, Smit C, Schommers P, Thornton A, Berenguer J et al. Ann Intern Med, 2017 01 03, Volume 166, Issue 1, p.9-17, (2017)
Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study. Warren-Gash C, Childs K, Thornton A, Bhagani S, Demma S, Srivastava A, Leen C, Agarwal K, Rodger A and Sabin C. Infection, 2017 Apr, Volume 45, Issue 2, p.215-220, (2017)
Development and application of a new measure of engagement in out-patient HIV care. Howarth A, Burns F, Apea V, Jose S, Hill T, Delpech V, Evans A, Mercer C, Michie S, Morris S et al. HIV Med, 2017 Apr, Volume 18, Issue 4, p.267-274, (2017)
Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study. O'Connor J, Smith C, Lampe F, Johnson M, Chadwick D, Nelson M, Dunn D, Winston A, Post F, Sabin C et al. Lancet HIV, 2017 May 04, (2017)
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older. The HIV-CAUSAL Collaboration. Lodi S, Costagliola D, Sabin C, Del Amo J, Logan R, Abgrall S, Reiss P, van Sighem A, Jose S, Blanco J et al. J Acquir Immune Defic Syndr, Volume 76, p.311-318, (2017)
Factors associated with rapid eGFR decline in patients receiving TDF and/or ATV. Hamzah L, Jose S, Jones R, Williams D, Chadwick D, Phillips A, Sabin C and Post F. CROI 2017, Volume Top Antivir Med. 2017;25(supp 1):273s, p.Abstract 650 Poster, (2017)
Growing up with perinatal HIV: changes in clinical outcomes before and after transfer to adult care in the UK. Judd A, Collins I, Parrott F, Hill T, Jose S, Ford D, Asad H, Gibb D and Sabin C. J Int AIDS Soc, 2017 May 16, Volume 20, Issue Suppl 3, p.71-80, (2017)
Hepatitis B, hepatitis C, and mortality among HIV-positive individuals. Thornton A, Jose S, Bhagani S, Chadwick D, Dunn D, Gilson R, Main J, Nelson M, Rodger A, Taylor C et al. AIDS, Volume 31, p.2525-32, (2017)